Specifically, in the case of myelomas, considering the information mentioned previously, the increased expression of the IL-6 receptor in response to heightened IL-6 release is suggested as a promising target for diagnoses and therapeutic interventions [30]. The gene discussed is IL6; the disease is plasma cell myeloma.